Biotech

All Articles

A closer take a look at Brutal Biotech's Ferocious 15

.In this particular full week's incident of "The Leading Pipe," we're diving in to Intense Biotech's...

Lilly deals with phase 2 failure of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event celebrating the approval of Alz...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of considerable management hirings, firings as w...

Lykos will certainly talk to FDA to rethink its choice observing rejection of MDMA treatment for post-traumatic stress disorder

.Complying with a poor presenting for Lykos Rehabs' MDMA prospect for post-traumatic stress disorder...

AN 2 halves head count, ceases period 3 trial after information disappoint

.AN2 Therapies is reviewing its company in feedback to uninspired midphase records, pledging to give...

Merck pays for $700M for bispecific, spying autoimmune position and chance to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand upfront to test Amgen in a blood stream cancer ...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA selection for its own liver illness medication seladelp...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may see the firms putting together outdoors tents at basecamp b...

Entero laying off workers, vacating workplace and also pausing R&ampD

.Mattress Liquidators has turned Entero Therapeutics white colored as a sheet. The lender bought Ent...

Exelixis falls ADC after deciding it's no match for Tivdak

.Exelixis is actually losing hope on its own cells variable (TF)- targeting antibody-drug conjugate ...